Modified Antibodies Trigger Immune Response, Point to Novel Vaccine Design ... Newswise (press release) Newswise — CAMBRIDGE, Mass. (January 7, 2013) – In an approach with the potential to aid therapeutic vaccine development, Whitehead Institute scientists have shown that enzymatically modified antibodies can be used to generate highly targeted, potent ... |
